Related Experiment Video
Updated: Jun 18, 2026

Intradermal Microdialysis: An Approach to Investigating Novel Mechanisms of Microvascular Dysfunction in Humans
Published on: July 21, 2023
Acute Effect of Topical (beta-Adrenergic Antagonists on Normal Perimacular Hemodynamics
A Harris1, J A Shoemaker, J Burgoyne
1*Department of Ophthalmology, and daggerDepartment of Physiology and Biophysics, Indiana University School of Medicine, Indianapolis, Indiana, U.S.A.
Purpose:
beta-adrenergic antagonists are the most commonly prescribed antiglaucoma medications. The nonselective beta blocker timolol has been shown to either increase or to not affect retinal blood flow, despite the suggestion that the drug may cause vasoconstriction due to its blockade of beta-2 receptors. Other beta blockers with unique pharmacologies may produce different effects on blood flow. We studied the effects of betaxolol (beta-1 selective antagonist), carteolol (nonselective beta-antagonist with intrinsic sympathomimetic activity), and levobunolol (nonselective beta antagonist with intrinsic sympathomimetic activity), and levobunolol (nonselective beta antagonist with active polar metabolite) on perimacular hemodynamics.
Method:
On four separate occasions separated by at least 10 days, 16 normal subjects performed measurements of heart rate, blood pressure, IOP, and blue field entoptic simulation assessment of leukocyte velocity and density before and 2 h after instillation of one of the three drugs or an artificial tears placebo.
Results:
IOP was significantly reduced by all three drugs as compared to placebo (p < 0.05, Bonferroni-corrected two-tailed paired t-test). No significant differences were found in heart rate, blood pressure, and perimacular leukocyte velocity or density in any of the treatment conditions as compared to placebo.
Conclusions:
Betaxolol, carteolol, and levobunolol do not appear to significantly alter perimacular hemodynamics 2 h after administration. The absence of any acute change in hemodynamics despite the drop in IOP suggests normal autoregulation maintained constant blood flow.
More Related Videos
05:58Testing Acetylcholine Followed by Adenosine for Invasive Diagnosis of Coronary Vasomotor Disorders
Published on: February 3, 2021
08:41Assessment of Vascular Tone Responsiveness using Isolated Mesenteric Arteries with a Focus on Modulation by Perivascular Adipose Tissues
Published on: June 3, 2019
Related Concept Videos
Adrenergic Antagonists: Pharmacological Actions of β-Receptor Blockers
Adrenergic Antagonists: ɑ and β-Receptor Blockers
Antianginal Drugs: Nitrates and β-Blockers
Organic nitrates, such as nitroglycerin, play a pivotal role. Once metabolized, they liberate nitric oxide, a molecular marvel. Nitric oxide triggers guanylyl cyclase and augments cGMP production. This biochemical cascade orchestrates the relaxation of vascular smooth muscles, ushering in vasodilation and enhancing coronary blood flow. Administered...
Antihypertensive Drugs: Action of β1 Blockers
Adrenergic Receptors: β Subtype
Isoprenaline > Adrenaline > Noradrenaline
Neurotransmitter binding to these receptors causes activation of adenylyl cyclase resulting in increased concentrations of cAMP and modulation of calcium ion channels within the cell. They are further classified into β1, β2, and β3 subtypes.
β1-adrenoceptors: β1-adrenoceptors have equal affinities for...
Adrenergic Agonists: Therapeutic Uses
Emergency and Intensive Care Unit (ICU) applications: Pressor agents increase blood pressure, heart rate, and contractility in shock and organ failure situations. Dopamine can induce vasodilation and stimulate adrenoceptors. Endogenous catecholamines are effective in treating cardiogenic shock. α2-agonists like clonidine can reverse anesthesia-induced hypertension.
Allergies and anaphylaxis:...